Compared across 2 stores. Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Zepbound is a once-weekly injectable prescription medicine built on tirzepatide, a dual GIP and GLP-1 receptor agonist. It lowers blood sugar by boosting insulin release and slowing glucose output from the liver, and it also drives substantial weight loss. This listing is the 12 mg/0.5 mL strength in a four-count pack of pen-style prefilled syringes that must stay refrigerated. It suits adults with type 2 diabetes or with obesity who have a prescription; it is not an over-the-counter product and competes with single-hormone GLP-1 drugs like semaglutide, which generally produce less weight loss in trials.
In stock
In stock
Lowest price we've seen: $1,199.99 on Nov 9 at TelyRx. Tracked across 2 stores since Nov 9.
Owners and clinicians report marked appetite suppression and steady weight loss, with many calling the pen easy to use. Most complaints center on gastrointestinal side effects, especially nausea and constipation, and on cost and supply.
Zepbound Tirzepatide is an injectable medicine that combines two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Each dose comes in a pen-style prefilled syringe at 12 mg/0.5 mL.
The medicine lowers blood sugar by increasing insulin production and slowing glucose release from the liver. It can also aid in weight loss. It is administered once weekly.
The package contains 4 prefilled pen-style syringes. It requires refrigeration.
